ArticleCancers2024

Evidence and Future Perspectives for Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Scoping Review.

Yutaka Endo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.